focus -WSS

focus

author：hotspot 2025-09-01 15:17:11 - browse：51774

Exact Sciences headquarters. -- biotech coverage from STAT — Exact Sciences' headquarters in Madison, Wis. Wikimedia Commons

Exact Sciences reported first-quarter revenues this week that beat market expectations, and the cancer detection company’s executives still believe they’re on track to meet expected 2024 revenue.

That’s usually good news. Yet Exact shares are down nearly 11% on Thursday, dipping to $53.12 within the first few hours of trading. During after-hours trading on Wednesday, shortly after Exact released its financial updates, shares tumbled as low as $47.24.

The seemingly paradoxical result reflects worries about a potential slowdown in future growth at Exact, a $10 billion biotech best known for Cologuard, a colon cancer screening test that detects blood and DNA from stool samples. The test, which first won regulatory approval in 2014, was designed to boost cancer screening rates by providing a more convenient alternative to colonoscopies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Biden’s NIH nominee is languishing in Congress

hotspot

WSS

Swim instructor mom warns parents not to buy blue swimsuits for kids

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Eisai exec who led development of Alzheimer’s drug to retire

Biden targets hefty hospital 'facility fees' that often surprise patients

Recent heat wave in the Mediterranean caused by climate change: Study

Chan Zuckerberg Biohub Chicago to focus on inflammation

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Hollywood unions extend contract negotiations for actors

Sana to lay off nearly a third of staff, de

Anesthesiologist group: stop taking Ozempic before surgery

Biden declares emergency in flood

Hepatitis C has a cure — but many Americans still lack access to it

Colorectal cancer study finds potential in overlooked immune cell

Malaria cases in Florida and Texas: Here’s what you need to know

Recent heat wave in the Mediterranean caused by climate change: Study

Medical records are filled with copy

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Wikipedia

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

FDA panel signals lack of confidence in Amgen cancer drug data

Swim instructor mom warns parents not to buy blue swimsuits for kids

VC firm General Catalyst wants to buy a health system

What to expect at HLTH 2023, the health care industry conference

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

knowledge

hotspot

knowledge

Wikipedia